Sr Consultants Inc. Report issue

For profit Phase 3
Founded: North Bethesda MD United States (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2005
NCT00690092
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

Coccidioides immitis Spherule - Derived Skin Test Antigen (Spherusol) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coccidioidomycosis (Phase 3)

Coccidiosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1